| Literature DB >> 28421121 |
Guanying Hu1, Cheng Peng1, Xiaofang Xie1, Sanyin Zhang2, Xiaoyu Cao1.
Abstract
Patchouli alcohol (PA), a tricyclic sesquiterpene, is one of the critical bioactive ingredients and is mainly isolated from aerial part of Pogostemon cablin (known as guanghuoxiang in China) belonging to Labiatae. So far, PA has been widely applied in perfume industries. This review was written with the use of reliable information published between 1974 and 2016 from libraries and electronic researches including NCKI, PubMed, Reaxys, ACS, ScienceDirect, Springer, and Wiley-Blackwell, aiming at presenting comprehensive outline of security, pharmacokinetics, and bioactivities of PA and at further providing a potential guide in exploring the PA and its use in various medical fields. We found that PA maybe was a low toxic drug that was acquired numerously through vegetable oil isolation and chemical synthesis and its stability and low water dissolution were improved in pharmaceutics. It also possessed specific pharmacokinetic characteristics, such as two-compartment open model, first-order kinetic elimination, and certain biometabolism and biotransformation process, and was shown to have multiple biological activities, that is, immunomodulatory, anti-inflammatory, antioxidative, antitumor, antimicrobial, insecticidal, antiatherogenic, antiemetic, whitening, and sedative activity. However, the systematic evaluations of preparation, pharmaceutics, toxicology, pharmacokinetics, and bioactivities underlying molecular mechanisms of action also required further investigation prior to practices of PA in clinic.Entities:
Year: 2017 PMID: 28421121 PMCID: PMC5379095 DOI: 10.1155/2017/4850612
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Scheme 1The list of antimicrobial and insecticidal activity of PA.
| Numbers | Tested mode | Tested subject | Parameters | References |
|---|---|---|---|---|
| Bacteria | ||||
|
| ||||
| 1 | In vitro |
| MIC = 1.0 mg/mL | [ |
| 2 | In vitro |
| MIC = 3.5 mg/mL | [ |
| 3 | In vitro |
| MIC = 3.5 mg/mL | [ |
| 4 | In vitro |
| MIC = 3.0 mg/mL | [ |
| 5 | In vitro |
| MIC = 6.5 mg/mL | [ |
| 6 | In vitro |
| MIC = 2.0 mg/mL | [ |
| 7 | In vitro |
| MIC = 78 | [ |
|
| ||||
| Viruses | ||||
|
| ||||
| 8 | In vitro | A/PR/8/34 (H1N1) | IC50 = 2.635 | [ |
| 9 | In vitro | B/Ibaraki/2/85 | IC50 = 40.82 | [ |
| 10 | In vivo | A/Leningrad/134/17/1957 (H2N2) infection mice | — | [ |
| 11 | In vitro | A/Leningrad/134/17/1957 (H2N2) | IC50 = 4.03 | [ |
| 12 | In vivo | A/FM1/1/47 (H1N1) infection mice | — | [ |
| 13 | In vitro | A/FM1/1/47 (H1N1) infection 16HBE | — | [ |
|
| ||||
| Fungus | ||||
|
| ||||
| 14 | In vitro |
| — | [ |
| 15 | In vitro |
| — | [ |
| 16 | In vitro |
| — | [ |
|
| ||||
| Termite | ||||
|
| ||||
| 17 | In vivo |
| LD50 = 4.57 | [ |
|
| ||||
| Mosquitoes | ||||
|
| ||||
| 18 | In vivo |
| — | [ |
| 19 | In vivo |
| — | [ |
| 20 | In vivo |
| — | [ |
|
| ||||
|
| ||||
|
| ||||
| 21 | In vivo |
| MLC > 200 | [ |
MIC, minimal inhibition concentration; IC50, 50% of lethal concentration; LD50, 50% of lethal dose; MLC, minimal lethal concentration.
Figure 1Possible mechanisms of bioactivities of PA in immunomodulation, antitumor, anti-inflammation, and antioxidation. Arrow up denotes activation or increase; arrow down denotes suppression or decrease. Inflammation and oxidation interact with each other.